USCOM Hemodynamic Monitoring
USCOM 1A uses advanced Doppler hemodynamics to monitor cardiac blood flow. Stroke Volume (SV) monitoring changes the way we manage fluid, inotropes, and vaso-actives, and how we diagnose and manage sepsis, heart failure and hypertension.
USCOM 1A uses advanced Doppler hemodynamics to monitor cardiac blood flow. Stroke Volume (SV) monitoring changes the way we manage fluid, inotropes, and vaso-actives, and how we diagnose and manage sepsis, heart failure and hypertension.
Fluid remains one of the most challenging clinical interventions and inappropriate administration has dire outcomes.
Sepsis is a medical emergency characterized by altered circulation, with death caused ultimately by circulatory failure.
Heart failure is the leading cause of death worldwide and early detection allows optimal management.
Hypertension damages the heart, vessels, brain and kidneys resulting in, at best, poor quality of life, while early detection and management of underlying hemodynamic derangements is crucial to improving therapy and outcomes.
The USCOM 1A is unique in being completely non-invasive, validated across a wide range of cardiac outputs in neonates, infants, children and adults, and is soundly patent protected.. Appropriate use of the USCOM 1A reduces mortality in septic shock patients.
Over 500 publications confirm the clinical utility of the USCOM 1A and demonstrate its outstanding reliability and reproducibility and role in clinical medicine – and it’s non-invasive
USCOM stands for Ultrasonic Cardiac Output Monitor. It measures blood flow across the heart valves using continuous wave Doppler ultrasound. It is the only truly non-invasive, accurate system of hemodynamic measurement.
USCOM uses specialized Doppler Ultrasound for measuring and monitoring hemodynamics. It provides noninvasive, accurate, real time, beat to beat, quantitative measures of cardiovascular function.
